Elevance Health (ELV) Set for Q1 Earnings Release

Author's Avatar
4 days ago
Article's Main Image

Quick Summary:

  • Elevance Health (ELV, Financial) is set to release its first-quarter earnings on April 22nd, with analysts forecasting strong results.
  • Wall Street shows confidence in ELV's performance, predicting a significant price increase from its current trading value.
  • GuruFocus metrics suggest an even larger potential upside based on the estimated GF Value.

Elevance Health Inc. (ELV) is poised to announce its first-quarter financial results on April 22nd. Analysts are anticipating an earnings per share (EPS) of $11.48 and total revenue reaching $46.25 billion for this period. Historically, the company has demonstrated robust performance, surpassing EPS expectations 75% of the time and revenue forecasts 88% of the time.

Wall Street Analysts Forecast

1914394012597514240.png

According to the insights of 19 financial analysts, the average 12-month price target for Elevance Health is $493.87, with projections ranging from a low of $428.00 to a high of $585.00. This average target price suggests a promising upside of 21.73% from the current trading price of $405.70. Investors can explore more detailed estimate data on the Elevance Health Inc (ELV, Financial) Forecast page.

In terms of brokerage recommendations, Elevance Health holds a favorable "Outperform" status with an average rating of 2.1 from 24 brokerage firms. The recommendation scale spans from 1 (Strong Buy) to 5 (Sell).

GuruFocus Estimates and GF Value

Utilizing GuruFocus metrics, the projected GF Value for Elevance Health Inc in a year's time stands at $622.26. This suggests a substantial upside potential of 53.38% from the current market price of $405.70. The GF Value is calculated by evaluating historical trading multiples, past business growth, and future business performance estimates. For comprehensive data and in-depth analysis, visit the Elevance Health Inc (ELV, Financial) Summary page.

Investors are advised to keep a watchful eye on these upcoming results and the accompanying market reactions, as Elevance Health continues to be an attractive player in the health sector with significant growth potential.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.